| Literature DB >> 29862149 |
Zijuan Qi1,2, Yazhou Cui2, Liang Shi2, Jing Luan2, Xiaoyan Zhou2, Jinxiang Han2.
Abstract
The aim of the study was to establish an induced pluripotent stem cell line from urine-derived cells (UiPSCs) from a patient with phenylketonuria (PKU) in order to provide a useful research tool with which to examine the pathology of this rare genetic metabolic disease. Urine-derived epithelial cells (UCs) from a 15-year-old male patient with PKU were isolated and reprogrammed with integration-free episomal vectors carrying an OCT4, SOX2, KLF4, and miR-302-367 cluster. PKU-UiPSCs were verified as correct using alkaline phosphatase staining. Pluripotency markers were detected with real-time PCR and flow cytometry. Promoter methylation in two pluripotent genes, NANOG and OCT4, was analyzed using bisulphite sequencing. An embryoid body (EB) formation assay was also performed. An induced pluripotent stem cell line (iPSC) was generated from epithelial cells in urine from a patient with PKU. This cell line had increased expression of stem cell biomarkers, it efficiently formed EBs, it stained positive for alkaline phosphatase (ALP), and it had a marked decrease in promoter methylation in the NANOG and OCT4 genes. The PKU-UiPSCs created here had typical characteristics and are suitable for further differentiation.Entities:
Keywords: Phenylketonuria; disease model; induced pluripotent stem cells; integration-free; urinary cells
Year: 2018 PMID: 29862149 PMCID: PMC5982629 DOI: 10.5582/irdr.2018.01032
Source DB: PubMed Journal: Intractable Rare Dis Res ISSN: 2186-3644